Early research (Phase 1)Study completedNCT01056965
What this trial is testing
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Who this might be right for
Predicted Tauopathies, IncludingProgressive Supranuclear PalsyFrontotemporal Dementia With Parkinsonism Linked to Chromosome 17+2 more
University of California, San Francisco 12